{
    "root": "c38c5db5-ebfb-5d56-d407-27f67a749aee",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Glycopyrrolate",
    "value": "20250521",
    "ingredients": [
        {
            "name": "GLYCOPYRROLATE",
            "code": "V92SO9WP2I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        }
    ],
    "indications": null,
    "contraindications": "NOTE: CONTAINS BENZYL ALCOHOL (see \n                        PRECAUTIONS\n                     ) \n                  Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.\n                  Glycopyrrolate injection may be administered intramuscularly, or intravenously, without dilution, in the following indications.",
    "warningsAndPrecautions": "Glycopyrrolate injection, USP, 0.2 mg/mL, is available in:\n                  \n                  1 mL single dose vials (NDC 16714-536-01) packaged in 25s (NDC 16714-536-25) 2 mL single dose vials (NDC 16714-620-01) packaged in 25s (NDC 16714-620-25) \n                  \n                  \n                     Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].\n                  \n                  To report SUSPECTED ADVERSE REACTIONS, contact Northstar Rx LLC at 1-800-206-7821, or the FDA at 1-800‑FDA‑1088 or www.fda.gov/medwatch.\n                  All registered trademarks in this document are the property of their respective owners.\n                  \n                  \n                     \n                        \n                           Manufactured by:\n                           Manufactured for:\n                        \n                        \n                           Indoco Remedies Limited L-32, 33, 34, Verna Industrial Area, Verna, Goa-403722, India\n                           Northstar Rx LLCMemphis, TN 38141\n                              \n                              \n                           \n                        \n                     \n                  \n                  Revised: April 2022",
    "adverseReactions": "Known hypersensitivity to glycopyrrolate or any of its inactive ingredients.\n                     In addition, in the management of peptic ulcer patients, because of the longer duration of therapy, glycopyrrolate injection may be contraindicated in patients with the following concurrent conditions: glaucoma; obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus, intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis."
}